People · Operator
Named in public records as an officer, director or promoter · active 2022–2026 · Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Trillium Renewable Chemicals, Inc. | Director | Other | Series B | $16.0M | $60.8M | 2026 |
| SimpleTherapy, Inc. | — | Other Health Care | Series A | $9.0M | $94.8M | 2022 |
Tae Won Kim at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tae Won Kim on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Corey Tyree | 1 | 2 |
| Erik Scher | 1 | 2 |
| Young Joon Lee | 1 | 2 |
| Wouter Van De Putte | 1 | 2 |
| Arpit Khemka | 1 | 1 |
| Norbert Baum | 1 | 1 |
| Harry Ledebur | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.